iShares U.S. Healthcare ETF News - October 3, 2026

Eli Lilly's Oral Foundayo Shows Cardiovascular Safety in Largest Diabetes Trial

Eli Lilly said its oral GLP-1 drug Foundayo demonstrated cardiovascular non-inferiority in the largest diabetes trial conducted to date. Cardiovascular safety...